Mobile Health Exercise Program for Myeloid Neoplasms
A Randomized Trial of a Mobile Health Exercise Intervention for Older Adults With Myeloid Neoplasms
Recruiting
N/A
Interventional Study
Cancer
Myeloid Neoplasm
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 60 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 170 (estimated)
- Sponsor
- University of Rochester · Other
Who this trial is looking for
This trial is looking for older adults who have myeloid neoplasms and are receiving cancer treatment. Participants will engage in a mobile health exercise program and share their experiences related to physical function and well-being.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 60 years old or older
- I have a diagnosis of myeloid neoplasm
- I am receiving outpatient cancer treatment
- I speak English
- I can walk 4 meters
- I have an acceptable performance status
- My doctor says I can exercise
- I can give my consent to participate
You may not be able to join if
- I have physical or mental conditions that interfere with my participation
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
This is a phase 2 randomized controlled trial (RCT) to assess the preliminary efficacy of the a mobile health exercise intervention (GO-EXCAP) versus a chemotherapy education control in 100 older patients with MN receiving outpatient chemotherapy on physical function and patient-reported outcomes (fatigue, mood, and quality of life). We will also explore the effect of the intervention on TNFα and …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥60 years (conventional definition of older age in clinical trials of MN)
* Have a diagnosis of MN
* Planned for or receiving outpatient cancer-directed treatments (participants receiving consolidative or maintenance outpatient therapies after induction chemotherapy are al…
Contacts